Peripheral blood mononuclear cell implantation for patients with severe ischemic heart disease
Not Applicable
- Conditions
- Severe ischemic heart disease
- Registration Number
- JPRN-UMIN000001289
- Lead Sponsor
- Department of Cardiovascular Science and Medicine,Graduate School of Medicine,Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
shock emergency operation malignant neoplasm severe retinopathy severe renal dysfunction(including who receiving chronic hemotherapy) femail with pregnancy others
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety throughout this treatment.
- Secondary Outcome Measures
Name Time Method Improvement of regional left ventriculer ejection fraction, gloval left ventriculer ejection fraction, perfusion, ischemic mitral regurgitation, symptom.